About
Anne Marije van Harten, Ph.D. is an Investment Director at Apollo Health Ventures, a transatlantic early-stage venture capital firm focused on biotechnology, healthspan, and age-related diseases. Apollo says she joined the firm in 2024 after working as an investment analyst at Forbion and training as a molecular cell biologist with a focus on oncology and targeted therapies. Publicly, she also appears as a board director at Booster Therapeutics and as a judge/speaker in longevity and biotech industry events.
Areas of interest
biotechdrug developmentoncologylongevityhealthspanage-related diseasesneurodegenerationprecision medicineventure capital